About CLINUVEL

RH

Product Offerings

 As can be gleaned from ‘Understanding CLINUVEL’ we place much emphasis on users’ abilities and eagerness to learn more about our products and services. In the 21st century CLINUVEL companies are in continuous dialogue with patients, consumers and all other interested parties, since information is key and distinguishes successful companies from each other.

Differing from other companies providing medicinal and skin care, we first provide information and knowledge surrounding our products and services. Each product in our hands has a story and reason of existence.

CLINUVEL’s expertise in pharmacology, pharmaceuticals, medicine, dermatology and many other specialties formed the foundation for our current product offerings. Typically, one would find in our products the elementary information on lotion versus emulsion, galenic formulation versus simple topical formulations, water base versus oil base. In our skin care product lines, we provide information on skin types, individual differences and complexions, products to avoid, ingredients, organics, naturals and more. Our scientists are keen to broadcast information on our fields of expertise and encourage users to seek knowledge while using our products.

Latest Company Announcements

26 March 2018

CLINUVEL Newsletter - March 2018

The erythropoietic protoporphyria (EPP) Expert Meeting in Vienna on 16 March has had quite an impact on our global teams working in the fields of photomedicine and melanocortins.

Read More
19 March 2018

CLINUVEL HOLDS EUROPEAN ERYTHROPOIETIC PROTOPORPHYRIA (EPP) EXPERT MEETING

CLINUVEL PHARMACEUTICALS LTD today announced the results of the third European meeting on erythropoietic protoporphyria (EPP) held in Vienna, Austria, on Friday 16 March.

Read More
21 February 2018

CLINUVEL sustains profitability first-half of year

CLINUVEL PHARMACEUTICALS LTD today announced financial results for the half year ended 31 December 2017, reporting net profit after tax of A$1.41m, and total revenues of A$7.19m.

Read More
13 February 2018

CLINUVEL unveils new global positioning

CLINUVEL PHARMACEUTICALS LTD today released its new global Company positioning including the unveiling of a new Group identity and website.

Read More
12 February 2018

CLINUVEL Newsletter - February 2018

We started this year with limitless optimism and energy, and I attribute this to a foundation of internal changes made over the past 16 months

Read More
31 January 2018

Appendix 3X - Karen Agersborg

Appendix 3X - Karen Agersborg

Read More

Quick Links